Furthermore, insertion of just a few nucleotides at position −8 was shown to create an enhancer in patients with T-ALL [14]; this enhancer was named “mutation of the TAL1 enhancer” (MuTE). This evidence concerns the gene TAL1 and acute lymphoblastic leukemia.